➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Baxter
McKesson
Merck
Colorcon

Last Updated: March 8, 2021

DrugPatentWatch Database Preview

Patent: 9,662,450

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,662,450
Title:Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus
Abstract: An article is described including an article surface, a primer coating or layer of SiOx, SiO.sub.xC.sub.y or SiN.sub.xC.sub.y applied to the article surface, and a deposit of lubricant applied to the primer coating or layer. The primer coating or layer of SiO.sub.x, SiO.sub.xC.sub.y or SiN.sub.xC.sub.y is applied by chemical vapor deposition of a polysiloxane or polysilazane precursor in the presence of oxygen. A first deposit of lubricant is applied to the primer coating or layer. The primer coating or layer improves the adhesion or wetting of the lubricant on the surface to be lubricated. Examples of such an article are a prefilled syringe having a barrel with a lubricated interior portion and a plunger tip that slides along it. Another example of such an article is a vial having a lubricated opening to receive a septum. Another aspect of the invention is a method of making such an article.
Inventor(s): Jones; Joseph A. (Birmingham, AL), Weikart; Christopher (Auburn, AL), Martin; Steven J. (Midland, MI)
Assignee: SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)
Application Number:14/194,221
Patent Claims:see list of patent claims

Details for Patent 9,662,450

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 001 2019-02-28   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX Orphan search
Wyeth Pharms Inc MYLOTARG gemtuzumab ozogamicin VIAL;SINGLE-DOSE 761060 001 2018-04-09   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX Orphan search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX search
Janssen Biotech STELARA ustekinumab INJECTABLE;INJECTION 761044 001 2019-11-07   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Merck
Baxter
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.